Oncogene-induced senescence as an initial barrier in lymphoma development
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Acute induction of oncogenic Ras provokes cellular senescence involving the retinoblastoma (Rb) pathway, but the tumour suppressive potential of senescence in vivo remains elusive. Recently, Rb-mediated silencing of growth-promoting genes by heterochromatin formation associated with methylation of histone H3 lysine 9 (H3K9me) was identified as a critical feature of cellular senescence, which may depend on the histone methyltransferase Suv39h1. Here we show that Emicro-N-Ras transgenic mice harbouring targeted heterozygous lesions at the Suv39h1, or the p53 locus for comparison, succumb to invasive T-cell lymphomas that lack expression of Suv39h1 or p53, respectively. By contrast, most N-Ras-transgenic wild-type ('control') animals develop a non-lymphoid neoplasia significantly later. Proliferation of primary lymphocytes is directly stalled by a Suv39h1-dependent, H3K9me-related senescent growth arrest in response to oncogenic Ras, thereby cancelling lymphomagenesis at an initial step. Suv39h1-deficient lymphoma cells grow rapidly but, unlike p53-deficient cells, remain highly susceptible to adriamycin-induced apoptosis. In contrast, only control, but not Suv39h1-deficient or p53-deficient, lymphomas senesce after drug therapy when apoptosis is blocked. These results identify H3K9me-mediated senescence as a novel Suv39h1-dependent tumour suppressor mechanism whose inactivation permits the formation of aggressive but apoptosis-competent lymphomas in response to oncogenic Ras.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in various mouse models, supported by correlative evidence from human- derived tissue samples, have underscored the tumour- suppressive role of OIS 81,120-123 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [120]
In the citing paper
“Oncogene-induced senescence protects against tumor initiation 34–37.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [36]
In the citing paper
“OIS is a powerful tumor suppressor mechanism 34–37.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [36]
In the citing paper
“a series of studies [22][23][24][25][26] identified senescence in several premalignant tumours, both in humans and mice.”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [22]
In the citing paper
“| DNA damage | Eμ-Nras G12V ; ectopic Bcl2 | Doxorubicin | Lymphoma regression | 22 | | | |”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [22]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Gene Action in the X-chromosome of the Mouse (Mus musculus L.)
LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978 · cited 1×
“5 with a T(6;15) translocation (see Supplementary Table 3 for details).”
BackgroundSelective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
Self-citationRegulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845 · cited 1×
“5 with a T(6;15) translocation (see Supplementary Table 3 for details).”
BackgroundSelf-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
Self-citationSibling rivalry in the E2F family
Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
Self-citation
Cited by
Items 501–600 of 1,001
Quantitative digital in situ senescence-associated β-galactosidase assay
Shlush, L. I., Itzkovitz, S., Cohen, A., Rutenberg, A., Berkovitz, R., Yehezkel, S., Shahar, H., Selig, S., & Skorecki, K. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-16 · Cited by 49
Significance of Cellular Senescence in Aging and Cancer
Grimes, A., & Chandra, S. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.4.187 · Cited by 68
Pawlikowski, J. S., Adams, P. D., & Nelson, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.109728 · Cited by 70
Lin, S., Yang, J., Elkahloun, A. G., Bandyopadhyay, A., Wang, L., Cornell, J. E., Yeh, I.-T., Agyin, J., Tomlinson, G., & Sun, L.-Z. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-10-0849 · Cited by 49
Sample-level enrichment analysis unravels shared stress phenotypes among multiple cancer types
Gundem, G., & López-Bigas, N. (2012) · Genome Medicine · doi:10.1186/gm327 · Cited by 56
Evasion of Cell Senescence Leads to Medulloblastoma Progression
Tamayo-Orrego, L., Wu, C., Bouchard, N., Khedher, A., Swikert, S. M., Remke, M., Skowron, P., Taylor, M. D., & Charron, F. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.061 · Cited by 58
Eberhardt, K., Beleites, C., Marthandan, S., Matthäus, C., Diekmann, S., & Popp, J. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04264 · Cited by 50
Komseli, E.-S., Pateras, I. S., Krejsgaard, T., Stawiski, K., Rizou, S. V., Polyzos, A., Roumelioti, F.-M., Chiourea, M., Mourkioti, I., Paparouna, E., et al. (2018) · BMC Genomics · doi:10.1186/s12864-017-4375-1 · Cited by 51
Diverse Roles of Cellular Senescence in Skeletal Muscle Inflammation, Regeneration, and Therapeutics
Saito, Y., & Chikenji, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739510 · Cited by 57
Nestorov, P., Tardat, M., & Peters, A. H. F. M. (2013) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416027-9.00008-5 · Cited by 54
Self-citationSenescence: an antiviral defense that is tumor suppressive?
Reddel, R. R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp274 · Cited by 50
MicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Redox Control of Cell Senescence
Lettieri-Barbato, D., Aquilano, K., Punziano, C., Minopoli, G., & Faraonio, R. (2022) · Antioxidants · doi:10.3390/antiox11030480 · Cited by 51
Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer
Kallenbach, J., Roozbahani, G. A., Horestani, M. H., & Baniahmad, A. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00941-0 · Cited by 58
Oncogene-induced senescence: An essential role for Runx
Terry, A., Cameron, E., Neil, J., & Kilbey, A. (2008) · Cell Cycle · doi:10.4161/cc.6368 · Cited by 46
Aberrant expression of p16INK4a in human cancers – a new biomarker?
Inoue, K., & Fry, E. A. (2018) · Cancer Reports and Reviews · doi:10.15761/crr.1000145 · Cited by 56
Cell senescence as both a dynamic and a static phenotype
Young, A. R. J., Narita, M., & Narita, M. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_1 · Cited by 50
The paradox of senescent-marker positive cancer cells: challenges and opportunities
O’Sullivan, E. A., Wallis, R., Mossa, F., & Bishop, C. L. (2024) · npj Aging · doi:10.1038/s41514-024-00168-y · Cited by 62
Pituitary senescence: The evolving role of Pttg
Chesnokova, V., & Melmed, S. K. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.012 · Cited by 53
Nijwening, J. H., Geutjes, E.-J., Bernards, R., & Beijersbergen, R. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025235 · Cited by 50
Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer
Majumder, M., Johnson, R. H., & Palanisamy, V. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1810621 · Cited by 56
Tu, Z., Zhuang, X., Yao, Y., & Zhang, R. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01744-12 · Cited by 54
Regulation of Pituitary Function by Cytokines
Haedo, M. R., Gerez, J., Fuertes, M., Giacomini, D., Páez-Pereda, M., Labeur, M. S., Renner, U., Stalla, G. K., & ARZT, E. S. (2009) · Hormone Research in Paediatrics · doi:10.1159/000245928 · Cited by 54
Zheng, H., Seit-Nebi, A., Han, X., Aslanian, A., Tat, J., Liao, R., Yates, J. R., & Sun, P. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.04.013 · Cited by 48
miR-125b induces cellular senescence in malignant melanoma
Nyholm, A. M., Lerche, C. M., Manfé, V., Biskup, E., Johansen, P., Morling, N., Thomsen, B. M., Glud, M., & Gniadecki, R. (2014) · BMC Dermatology · doi:10.1186/1471-5945-14-8 · Cited by 53
Lineage-Specific Restraint of Pituitary Gonadotroph Cell Adenoma Growth
Chesnokova, V., Zonis, S., Zhou, C., Ben-Shlomo, A., Wawrowsky, K., Toledano, Y., Tong, Y., Kovács, K., Scheithauer, B. W., & Melmed, S. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017924 · Cited by 50
Jailbreak: Oncogene-induced senescence and its evasion
MDuff, F. K. E., & Turner, S. D. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.07.004 · Cited by 56
Nakano, M., Nakashima, A., Nagano, T., Ishikawa, S., Kikkawa, U., & Kamada, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080411 · Cited by 47
Muñoz-Galván, S., Lucena-Cacace, A., Pérez, M., Otero-Albiol, D., Gómez-Cambronero, J., & Carnero, A. (2018) · Oncogene · doi:10.1038/s41388-018-0527-2 · Cited by 52
Liu, P., Tang, Q., Chen, M., Chen, W., Lu, Y., Liu, Z., & He, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.589908 · Cited by 56
Hernando, B., Dietzen, M., Parra, G., Gil‐Barrachina, M., Pitarch, G., Mahiques, L., Valcuende, F., McGranahan, N., & Martínez‐Cadenas, C. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.11.023 · Cited by 49
p16INK4a protects against dysfunctional telomere–induced ATR-dependent DNA damage responses
Wang, Y., Sharpless, N., & Chang, S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69574 · Cited by 48
Mechanisms involved in hematopoietic stem cell aging
Fujino, T., Asada, S., Goyama, S., & Kitamura, T. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04356-5 · Cited by 56
Mileo, A. M., Venere, D. D., Abbruzzese, C., & Miccadei, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/363827 · Cited by 59
DNA double strand break responses and chromatin alterations within the aging cell
Klement, K., & Goodarzi, A. A. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.003 · Cited by 53
CIP2A is overexpressed in esophageal squamous cell carcinoma
Qu, W., Li, W., Wei, L., Xing, L., Wang, X., & Yu, J. (2010) · Medical Oncology · doi:10.1007/s12032-010-9768-9 · Cited by 53
Heterochromatin dysregulation in human diseases
Hahn, M., Dambacher, S., & Schotta, G. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00053.2010 · Cited by 44
López-Vicente, L., Armengol, G., Pons, B., Coch, L., Argelaguet, E., LLeonart, M. E., Hernández‐Losa, J., de Torres, I. M., & y Cajal, S. R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3159 · Cited by 54
Choi, S.-Y., Bin, B.-H., Kim, W., Lee, E., Lee, T. R., & Cho, E. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.02.016 · Cited by 55
Moh, M. C., Zhang, T., Lee, L. H., & Shen, S. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn226 · Cited by 50
Bhatia, B., Multani, A. S., Patrawala, L., Chen, X., Calhoun‐Davis, T., Zhou, J., Schroeder, L., Schneider‐Broussard, R., Shen, J., Pathak, S., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23222 · Cited by 47
Evidence of oncogene-induced senescence in thyroid carcinogenesis
Vizioli, M. G., Possik, P. A., Tarantino, E., Meissl, K., Borrello, M. G., Miranda, C., Anania, M. C., Pagliardini, S., Seregni, E., Pierotti, M. A., et al. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0240 · Cited by 47
Crosstalk between gut microbiota and cellular senescence: a vicious cycle leading to aging gut
Kawamoto, S., & Hara, E. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.12.004 · Cited by 49
Knockdown of AGR2 induces cellular senescence in prostate cancer cells
Hu, Z., Gu, Y., Han, B., Zhang, J., Li, Z., Tian, K., Young, C. Y. F., & Yuan, H. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs141 · Cited by 49
Growth arrest signaling of the Raf/MEK/ERK pathway in cancer
Park, J. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1299-x · Cited by 51
Cellular senescence: friend or foe to respiratory viral infections?
Kelley, W. J., Zemans, R. L., & Goldstein, D. R. (2020) · European Respiratory Journal · doi:10.1183/13993003.02708-2020 · Cited by 45
Cellular senescence and hematological malignancies: From pathogenesis to therapeutics
Hu, D., Yuan, S., Zhong, J., Liu, Z., Wang, Y., Liu, L., Li, J., Wen, F., Liu, J., & Zhang, J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107817 · Cited by 49
Suraneni, M. V., Schneider‐Broussard, R., Moore, J. R., Davis, T., Maldonado, C. J., Li, H., Newman, R. A., Kusewitt, D. F., HU, J. L., Yang, P., et al. (2010) · Oncogene · doi:10.1038/onc.2010.197 · Cited by 47
Escape from oncogene-induced senescence is controlled by POU2F2 and memorized by chromatin scars
Martínez‐Zamudio, R. I., Stefa, A., de Freitas, J. A. N. L. F., Vasilopoulos, T., Simpson, M., Doré, G. R. G., Roux, P., Galan, M. A., Chokshi, R. J., Bischof, O., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100293 · Cited by 52
Senescence, NK cells, and cancer: navigating the crossroads of aging and disease
Gergues, M., Bari, R., Koppisetti, S., Gosiewska, A., Kang, L., & HARIRI, R. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1565278 · Cited by 52
Klepacki, H., Kowalczuk, K., Łepkowska, N., & Hermanowicz, J. M. (2025) · Cells · doi:10.3390/cells14130942 · Cited by 57
Small-molecular modulators of cancer-associated epigenetic mechanisms
Itoh, Y., Suzuki, T., & Miyata, N. (2013) · Molecular BioSystems · doi:10.1039/c3mb25410k · Cited by 44
Litwiniec, A., Grzanka, A., Helmin–Basa, A., Gackowska, L., & Grzanka, D. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0711-4 · Cited by 50
Extracellular acidosis triggers a senescence‐like phenotype in human melanoma cells
Böhme, I., & Bosserhoff, A. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12811 · Cited by 61
Epigenetic reprogramming of liver cells in tamoxifen‐induced rat hepatocarcinogenesis
Tryndyak, V., Kovalchuk, O., Muskhelishvili, L., Montgomery, B. A., Rodriguez‐Juarez, R., Melnyk, S., Ross, S. A., Beland, F. A., & Pogribny, I. P. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20263 · Cited by 48
The role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
Cellular Senescence as a Target in Cancer Control
Vergel, M., Marin, J. J., Estevez, P., & Carnero, A. (2011) · Journal of Aging Research · doi:10.4061/2011/725365 · Cited by 44
Bulynko, Y. A., Hsing, L. C., Mason, R. W., Tremethick, D. J., & Grigoryev, S. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00135-06 · Cited by 49
Large cell change of hepatocytes in chronic viral hepatitis represents a senescent-related lesion
Ikeda, H., Sasaki, M., Sato, Y., Harada, K., Zen, Y., Mitsui, T., & Nakanuma, Y. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.06.009 · Cited by 44
Role of senescence induction in cancer treatment
Qin, S., Schulte, B. A., & Wang, G. Y. (2018) · World Journal of Clinical Oncology · doi:10.5306/wjco.v9.i8.180 · Cited by 45
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
Xue, L., Nolla, H., Suzuki, A., Mak, T. W., & Winoto, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712059105 · Cited by 44
Khanal, P., Kim, G., Lim, S., Yun, H., Lee, K. Y., Choi, H., & Choi, H. S. (2013) · The FASEB Journal · doi:10.1096/fj.13-236851 · Cited by 47
Cellular senescence in tissue repair: every cloud has a silver lining
Yun, M. H. (2018) · The International Journal of Developmental Biology · doi:10.1387/ijdb.180081my · Cited by 41
Kuo, M.-L., Sy, A. J., Xue, L., Chi, M., -C. Lee, M. T., Yen, T., Chiang, M.-I., Chang, L., Chu, P., & Yen, Y. (2012) · Scientific Reports · doi:10.1038/srep00822 · Cited by 43
PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo
Parisotto, M., Grelet, E., El Bizri, R., Dai, Y., Terzic, J., Eckert, D., Gargowitsch, L., Bornert, J.-M., & Metzger, D. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171207 · Cited by 43
“Oncogene-induced senescence (OIS), by permanently halting cell proliferation and promoting immune surveillance of premalignant lesions, is a barrier against cell transformation (Braig et al., 2005; Chen et al., 2005; Kang et al., 2011).”
BackgroundThe foreign body response: emerging cell types and considerations for targeted therapeutics
Yang, B., Rutkowski, N., & Elisseeff, J. H. (2023) · Biomaterials Science · doi:10.1039/d3bm00629h · Cited by 46
Role of 2-5A-dependent RNase-L in senescence and longevity
Andersen, J. B., Li, X. L., Judge, C. S., Zhou, A., Jha, B. K., Shelby, S., Zhou, L., Silverman, R. H., & Hassel, B. A. (2006) · Oncogene · doi:10.1038/sj.onc.1210111 · Cited by 49
Lee, T., Paola, D. D., Malina, A., Mills, J. R., Kreps, A., Große, F., Tang, H., Zannis‐Hadjopoulos, M., Larsson, O. S., & Pelletier, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568535 · Cited by 50
Lohse, B., Nielsen, A. L., Kristensen, J. B. L., Helgstrand, C., Cloos, P. A., Olsen, L., Gajhede, M., Clausen, R. P., & Kristensen, J. L. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101849 · Cited by 48
Unphosphorylated STAT3 in heterochromatin formation and tumor suppression in lung cancer
Dutta, P., Zhang, L., Zhang, H., Peng, Q., Montgrain, P. R., Wang, Y., Song, Y., Li, J., & Li, W. X. (2020) · BMC Cancer · doi:10.1186/s12885-020-6649-2 · Cited by 46
Singh, K., Pruski, M. A., Bland, R., Younes, M., Guha, S., Thosani, N. C., Maitra, A., Cash, B. D., McAllister, F. M., Logsdon, C. D., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00490-5 · Cited by 46
Senescence-mediated anticancer effects of quercetin
Özsoy, S., Becer, E., & Vatansever, H. S. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.04.007 · Cited by 46
The Role of Histone Modifications in Epigenetic Transitions During Normal and Perturbed Development
Kubicek, S., Schotta, G., Lachner, M., Sengupta, R., Kohlmaier, A., Perez-Burgos, L., Linderson, Y., Martens, J. H. A., O’Sullivan, R. J., Fodor, B. D., et al. (2006) · Springer eBooks · doi:10.1007/3-540-37633-x_1 · Cited by 56
Self-citationAhsan, M. K., & Mehal, W. Z. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00069 · Cited by 46
Graf, M., Hartmann, N., Reichwald, K., & Englert, C. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.02.012 · Cited by 45
Epigenetic Control of Hematopoietic Stem Cell Aging The Case of Ezh2
de Haan, G., & GERRITS, A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1392.008 · Cited by 46
Sashida, G., Liu, Y., Elf, S., Miyata, Y., Ohyashiki, K., Izumi, M., Menéndez, S., & Nimer, S. D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01551-08 · Cited by 44
Programmed cell senescence: role of IL-6 in the pituitary
Sapochnik, M., Fuertes, M., & ARZT, E. S. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0026 · Cited by 44
Aging tumour cells to cure cancer: “pro-senescence” therapy for cancer
Calcinotto, A., & Alimonti, A. (2017) · Swiss Medical Weekly · doi:10.57187/smw.2017.14367 · Cited by 45
Cellular senescence: from anti-cancer weapon to anti-aging target
Yuan, L., Alexander, P. B., & Wang, X. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1629-6 · Cited by 42
Insights from In Vivo Studies of Cellular Senescence
Prieto, L. I., Graves, S. I., & Baker, D. J. (2020) · Cells · doi:10.3390/cells9040954 · Cited by 41
Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence
Shin, J., Yang, J., Lee, J. C., & Baek, K. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.014 · Cited by 44
Pan, Y., Meng, M., Zheng, N., Cao, Z., Yang, P., Xi, X., & Zhou, Q. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.024 · Cited by 42
SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia
Chu, Y., Chen, Y., Guo, H., Li, M., Wang, B., Shi, D., Cheng, X., Guan, J., Wang, X., Xue, C., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01495-6 · Cited by 45
Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells
Morsli, S., Doherty, G. J., & Muñoz-Espín, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111618 · Cited by 42
Pancreatic Cancer Development and Progression: Remodeling the Model
Real, F. X., Cibrián–Uhalte, E., & Martinelli, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.033 · Cited by 49
SnoN functions as a tumour suppressor by inducing premature senescence
Pan, D., Zhu, Q., & Luo, K. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.250 · Cited by 45
Chromosome instability and deregulated proliferation: an unavoidable duo
Coschi, C. H., & Dick, F. A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0910-4 · Cited by 42
The extent of liver injury determines hepatocyte fate toward senescence or cancer
Wang, C., Chen, W., Wu, Y., You, P., Zheng, S., Liu, C.-C., Xiang, D., Wang, M., Cai, Y., Zhao, Q., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0622-x · Cited by 41
Induction and transmission of oncogene-induced senescence
Rattanavirotkul, N., Kirschner, K., & Chandra, T. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03638-0 · Cited by 44
Xu, Q., Ma, P., Hu, C., Chen, L., Xue, L., Wang, Z., Liu, M., Zhu, H., Xu, N., & Lu, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041862 · Cited by 39
Hallmarks for senescence in carcinogenesis: novel signaling players
Caino, M. C., Meshki, J., & Kazanietz, M. G. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0316-z · Cited by 54
Marthandan, S., Menzel, U., Priebe, S., Groth, M., Guthke, R., Platzer, M., Hemmerich, P., Kaether, C., & Diekmann, S. (2016) · Biological Research · doi:10.1186/s40659-016-0095-2 · Cited by 39
Metabolic alterations accompanying oncogene-induced senescence
Aird, K. M., & Zhang, R. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.963481 · Cited by 39
HER2-mTOR signaling–driven breast cancer cells require ER-associated degradation to survive
Singh, N., Joshi, R., & Komurov, K. (2015) · Science Signaling · doi:10.1126/scisignal.aaa6922 · Cited by 39
Tumor Dormancy, Oncogene Addiction, Cellular Senescence, and Self-Renewal Programs
Bellovin, D. I., Das, B., & Felsher, D. W. (2013) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-1445-2_6 · Cited by 39
Lee, Y., Chen, Y.-Y., Yeh, Y.-L., Wang, Y., & Chen, R.-J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112716 · Cited by 41
Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies
Fakhri, S., Moradi, S. Z., DeLiberto, L. K., & Bishayee, A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114989 · Cited by 42
Sherman, M. Y., Le, M., Stampfer, M. R., Gabai, V. L., & Yaglom, J. A. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00736.x · Cited by 41
Aberrant methylation of the M-type phospholipase A2 receptor gene in leukemic cells
Menschikowski, M., Platzbecker, U., Hagelgans, A., Vogel, M., Thiede, C., Schönefeldt, C., Lehnert, R., Eisenhofer, G., & Siegert, G. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-576 · Cited by 42
Li, B., Luo, C., Li, H., Yang, P., Zhang, M., Xu, H., Xu, H., Shen, Y., Xue, A., & Zhao, Z. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.662 · Cited by 41
Metadata
- Authors
- Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Medizinische Hochschule Hannover (DE)
- Research Institute of Molecular Pathology (AT)
- Max Delbrück Center (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2005-08
- Volume
- 436
- Issue
- 7051
- Pages
- 660-665
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2080769506
- Cited by
- 1,220
- References
- 31
- Citations by year
- 2026: 19 · 2025: 37 · 2024: 34 · 2023: 54 · 2022: 42 · 2021: 57 · 2020: 57 · 2019: 49 · 2018: 49 · 2017: 44 · 2016: 58 · 2015: 53 · 2014: 51 · 2013: 86 · 2012: 69
- FWCI
- 43.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- cellular senescence, lymphoma, oncogenic Ras, SUV39H1, H3K9 methylation, heterochromatin, retinoblastoma pathway, p53, T-cell lymphoma, tumor suppression, epigenetic silencing, histone methyltransferase
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Disease Models, Animal, Heterochromatin, Lymphoma, Methylation, Methyltransferases, Mice, Transgenic, Precancerous Conditions, Genes, ras, Repressor Proteins, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Cellular Senescence, Apoptosis, Disease Progression, Transgenes, ADP-Ribosylation Factors, Chromosomal Instability, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.